A mental health nurse faced the Nursing and Midwifery Council’s fitness-to-practise panel after they were seen inappropriately restraining a patient on several occasions.
Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology indications and cancer types.
Breast cancer care differs around the world, revealing urgent unmet needs in Nepal, where access, support, and treatment remain out of reach for many.
This spring, ACCC hosted 2 virtual office hours sessions featuring oncology pharmacists with expertise in using bispecific antibodies. Participants shared practical insights, challenges, and strategies…
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can help guides treatment decisions.
Editor-in-Chief: Krista Nelson, LCSW, OSW-C, FAOSW, FAPOS, FACCC Oncology Issues, Article, Volume 40, Osteosarcoma, a rare type of bone cancer that primarily affects adolescents and…
I celebrated five years since my bone marrow transplant with a surprise video from my donor, a beautiful reminder of the life she helped me…
Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, HER2-negative stage 4 breast cancer.
Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and cancer-related bone conditions.
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Read about a nurse-led project which has developed a tool to support people with a learning disability to access urgent and emergency care.
